Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant chemotherapy with or without WTPA for HER2-negative locally advanced breast cancer
ChiCTR-TRC-10000794Phase 4Completed
- Sponsor
- Fudan University Shanghai Cancer Center
- Start
- Mar 2010
- Modality
- Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Live Biotherapeutic Products → Microbiome Therapeutics, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in breast cancer comparing Neoadjuvant chemotherapy + WTPA with Neoadjuvant chemotherapy + placebo (2 arms). Primary endpoint: Pathological complete response. Started Mar 2010; status: completed.
02
Drugs
pseudomonas aeruginosa injection
03
Conditions
breast cancer
Beyond the preview
Go deeper on ChiCTR-TRC-10000794.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-10000794.